Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.96 +0.12 (+0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Other Accumulated Expenses (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) posted Other Accumulated Expenses of $36.78 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 32.5% from $27.76 million a year earlier and up 16.9% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Other Accumulated Expenses came in at $30.71 million, down 10.9% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 41.5% (FY2020 to FY2025).
  • In prior fiscal years, Enanta Pharmaceuticals' Other Accumulated Expenses was $34.46 million in FY2024 (-1.8%), $35.08 million in FY2023 (+534.1%), $5.53 million in FY2022 (-8.7%) and $6.06 million in FY2021 (+12.1%).
  • The fiscal Q3 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to fiscal Q4 2012.
  • On a year-over-year basis, Other Accumulated Expenses increased in two of the last eight quarters, with an average decline of 1.6%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was fiscal Q3 2023, with growth of 780.1%; the weakest was fiscal Q2 2023, with a decline of 62.7%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior fiscal quarters was $31.46 million (Q2 2026), $31.98 million (Q1 2026) and $30.71 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Enanta Pharmaceuticals 377.40 Mn -350.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.78 Mn
Mar 31, 2026 31.46 Mn
Dec 31, 2025 31.98 Mn
Sep 30, 2025 30.71 Mn
Jun 30, 2025 27.76 Mn
Mar 31, 2025 30.68 Mn
Dec 31, 2024 32.74 Mn
Sep 30, 2024 34.46 Mn
Jun 30, 2024 32.30 Mn
Mar 31, 2024 33.67 Mn
Dec 31, 2023 36.51 Mn
Sep 30, 2023 35.08 Mn
Jun 30, 2023 36.69 Mn
Mar 31, 2023 5.38 Mn
Dec 31, 2022 6.86 Mn
Sep 30, 2022 5.53 Mn
Jun 30, 2022 4.17 Mn
Mar 31, 2022 14.41 Mn
Dec 31, 2021 6.45 Mn
Sep 30, 2021 6.06 Mn
API Access

Enanta Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY